Skip to main content Skip to main menu
UF Health University of Florida
Department of Pharmacotherapy and Translational Research College of Pharmacy
Apply to Ph.D. Program
Haylee R Hammond

Haylee R Hammond

GRADUATE AST-G

Department: Cellular and Systems Pharmacology
Business Phone: (321) 698-9613
Business Email: hhammond@ufl.edu

On This Page

Board Certifications

  • Pharmacist License
    Florida Board of Pharmacy

Publications

Academic Articles

  1. Characterization of Novel Sigma Receptor Ligands Derived from Multicomponent Reactions as Efficacious Treatments for Neuropathic Pain.

    Journal
    Pharmaceuticals (Basel, Switzerland).
    Volume/Issue
    19(1)
    [DOI]
    10.3390/ph19010117.
    [PMID]
    41599715.
    PubMed Publisher’s Site

  2. Peripherally Restricted Fused Heterocyclic Peptidomimetic Multifunctional Opioid Agonists as Novel, Potent Analgesics.

    Journal
    ACS medicinal chemistry letters.
    Volume/Issue
    16(3):388-396
    [DOI]
    10.1021/acsmedchemlett.4c00333.
    [PMID]
    40104791.
    1 citation PubMed Publisher’s Site

  3. Structure-guided design of partial agonists at an opioid receptor.

    Journal
    Nature communications.
    Volume/Issue
    16(1)
    [DOI]
    10.1038/s41467-025-57734-5.
    [PMID]
    40082451.
    8 citations PubMed Publisher’s Site

  4. A µ-opioid receptor modulator that works cooperatively with naloxone.

    Journal
    Nature.
    Volume/Issue
    631(8021):686-693
    [DOI]
    10.1038/s41586-024-07587-7.
    [PMID]
    38961287.
    27 citations PubMed Publisher’s Site

  5. SRI-30827, a novel allosteric modulator of the dopamine transporter, alleviates HIV-1 Tat-induced potentiation of cocaine conditioned place preference in mice

    Journal
    NeuroImmune Pharmacology and Therapeutics.
    Volume/Issue
    3(1):1-6
    [DOI]
    10.1515/nipt-2023-0022.
    [PMID]
    38711842.
    PubMed Publisher’s Site

  6. SRI-32743, a novel allosteric modulator, attenuates HIV-1 Tat protein-induced inhibition of the dopamine transporter and alleviates the potentiation of cocaine reward in HIV-1 Tat transgenic mice.

    Journal
    Neuropharmacology.
    Volume/Issue
    220
    [DOI]
    10.1016/j.neuropharm.2022.109239.
    [PMID]
    36126727.
    17 citations PubMed Publisher’s Site

Presentations

  1. Positive allosteric modulation of DAT reverses HIV-Tat protein-mediated deficits

    International / Invited. [Poster]. International Narcotics Research Conference, Gainesville, FL

  2. Positive allosteric modulation of DAT by SRI-32743 reverses HIV-Tat protein-mediated cognitive decline and cocaine-seeking behavior in mice

    Regional / Invited. [Poster]. University of Florida College of Pharmacy Research Showcase, Gainesville, FL

  3. Negative Allosteric Modulation of µ-Opioid Receptor Blocks Agonist Activity and Enhances Naloxone

    Regional / Invited. [Lecture]. University of Florida College of Pharmacy Research Showcase, Gainesville, FL

  4. Negative Allosteric Modulation of µ-Opioid Receptor Blocks Agonist Activity and Enhances Naloxone

    State / Invited. [Poster]. UF CARE Annual Symposium, Gainesville, FL

Education

  1. PharmD

    University of Florida, College of Pharmacy

  2. BS Microbiology and Cell Science

    University of Florida, College of Liberal Arts and Sciences

Contact Details

Phones:
Business:
(321) 698-9613
Emails:
Business:
hhammond@ufl.edu
Addresses:
Business Street:
1225 CENTER DR
 GAINESVILLE FL 32610